GE HealthCare (Nasdaq: GEHC) announced today that it launched its Invenia automated breast ultrasound (ABUS) premium offering.

University of Queensland researchers have developed a new rapid sensor that can detect pregnancy complications, such as gestational diabetes, preterm birth risks and hypertension, as early as 11 weeks—with a simple blood test.

UroMems announced that the entire treatment cohort in the first-of-its-kind study in female patients successfully reached its primary endpoints.

A debilitating condition affecting 1 in 4 women is desperately crying out for a solution, and the next generation of treatments to repair the damage of pelvic organ prolapse (POP) has just come a big step closer.

In a study, which has been published in Nature Medicine, a team of researchers from ETH Zurich, the University Hospitals of Basel and Zurich, and the Basel-Land Cantonal Hospital, shows a new, promising approach

PALO ALTO, Calif., Jan. 21, 2025 /PRNewswire/ — Glooko, Inc., a global integrated digital health company connecting patients, providers, biopharma, and medical device partners, today announced that its Glooko XT solution has been approved for reimbursement by the Haute Autorité de Santé (HAS) and the Commission Nationale d’Évaluation des Dispositifs Médicaux et des Technologies de Santé (CNEDiMTS) in France.

IRVINE, Calif., Dec. 2, 2024 /PRNewswire/ — Mentor Worldwide LLC, the number one global brand in breast aesthetics, and part of Johnson & Johnson MedTech, today announced the U.S. Food and Drug Administration (FDA) approved MENTOR™ MemoryGel™ Enhance Breast Implants for primary and revision reconstruction breast surgery in post-mastectomy women.

The drug-device combination developed by MIT spinout Lumicell is poised to reduce repeat surgeries and ensure more complete tumor removal.

Mira has launched Mira Hormone Monitor: Menopause Transitions Kit to help women aged 35 and older track their hormones to spot early signs of perimenopause and manage them effectively.